Adams Street Partners LLC Aptinyx Inc. Transaction History

Adams Street Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	BUY	$2.39 - $3.5 $215,396 - $315,434	90,124 Added 1.7%	5,395,996 $15.3 Million
Q3 2020 Nov 13, 2020	BUY	$3.05 - $4.99 $274,878 - $449,718	90,124 Added 1.73%	5,305,872 $17.9 Million
Q1 2020 May 14, 2020	BUY	$1.81 - $5.03 $1.97 Million - $5.48 Million	1,090,124 Added 26.42%	5,215,748 $11.3 Million
Q1 2019 May 14, 2019	BUY	$3.99 - $19.33 $379,034 - $1.84 Million	94,996 Added 2.36%	4,125,624 $16.7 Million
Q2 2018 Aug 13, 2018	BUY	$19.83 - $24.17 $79.9 Million - $97.4 Million	4,030,628 New	4,030,628 $87.7 Million

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Adams Street Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Adams Street Partners LLC with notifications on news.